Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Complete Revascularisation Following Acute MI
Author(s): Ahmed Gonnah , Nadhrah Darke , Liam Mullen , et al Added: 7 months ago

MI/ACS

Prevention & Chronic Conditions
The STEMI Door-to-Unload (DTU) Clinical Trial Programme
Author(s): Navin K Kapur Added: 1 year ago

Intervention
Predilation in pPCI
Author(s): Mahmoud Tantawy , Marwan Saad , Sherif Hussien , et al Added: 6 months ago

Intervention

MI/ACS
FIRE Trial: Sustained Benefit of Complete Revascularization in Older MI Patients at 3 Years
Added: 1 month ago Source:  Transcatheter Academy
The long-term durability of complete revascularization in older patients with myocardial infarction (MI) and multivessel disease has been a subject of recent debate. New 3-year follow-up data from the Functional Assessment in Elderly MI Patients With Multivessel Disease (FIRE) trial show that the clinical benefits of a physiology-guided complete revascularization strategy are sustained over time… View more

Demographic

Heart Failure
Is Unloading the Left Ventricle the Key to Improving Survival in Anterior Wall Acute MI?
Author(s): William O’Neill Added: 1 year ago

Intervention
Immediate vs Deferred PCI in STEMI: iMODERN Trial Results
Added: 1 week ago Source:  Radcliffe Cardiology
The optimal timing for treating nonculprit lesions in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease remains a key clinical question. The iMODERN trial investigated whether an immediate intervention strategy was superior to a deferred approach in this patient population.¹The international, investigator-initiated, open-label iMODERN (Immediate or Deferred… View more

Imaging & Diagnostics

Intervention
Early Heparin in STEMI Improves Artery Patency: HELP-PCI
Added: 2 weeks ago Source:  Transcatheter Academy
The optimal timing for administering unfractionated heparin (UFH) to patients with ST-elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PPCI) has been a topic of discussion. The HELP-PCI trial investigated whether pre-treatment with UFH at first medical contact (FMC) improves outcomes compared to administration in the catheterisation laboratory (Cath… View more

Anticoagulation

Guidelines & Statements
TCT 23: PICSO-AMI-I: Pressure Controlled Intermittent Coronary Sinus Occlusion in Acute Myocardial Infarction.
Author(s): Giovanni Luigi Di Maria Added: 2 years ago
TCT 23 - We are joined by Dr Giovanni Luigi Di Maria (John Radcliffe Hospital, UK) to discuss the findings of the PICSO-AMI-I study (NCT04958421), sponsored by Miracor Medical. The PICSO-AMI-I study aimed to assess the safety and feasibility of pressure-controlled intermittent coronary sinus occlusion (PiCSO) in patients with ST-elevation myocardial infarction (MI), presenting with TIMI 0 or 1… View more

Intervention
ACC.24: FFR or Culprit-Only PCI in STEMI
Author(s): Felix Böhm Added: 1 year ago
ACC.24 — Investigator, Dr Felix Böhm (Danderyd Hospital, SE) joins us to discuss the findings from a study investigating fractional flow reserve-guided complete or culprit-only percutaneous coronary intervention (PCI) in patients with ST-elevation myocardial infarction (MI).1542 patients were enrolled in the trial, who were randomized 1:1 to receive either FFR-guided PCI of non-culprit lesions… View more

Intervention

MI/ACS
EuroPCR 25: The DANAMI-3-PRIMULTI Trial
Author(s): Thomas Engstrøm Added: 5 months ago
EuroPCR 25 - 10-year outcomes from DANAMI-3-PRIMULTI show FFR-guided complete revascularisation in ST-elevation myocardial infarction (STEMI) reduces the risk of future events. We are joined by Dr Thomas Engstrøm (University of Copenhagen, Copenhagen, Denmark) to discuss 10-year outcomes from the multicenter, randomized DANAMI-3-PRIMULTI trial investigating FFR-guided complete… View more

Demographic

MI/ACS